STOCK TITAN

Larimar Therapeutics, Inc. (LRMR) Net Income by Year

LRMR

Larimar Therapeutics, Inc. reported a net loss of $165.7M in fiscal year 2025. This represents a decrease of 105.5% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Larimar Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$165.7M
YoY -105.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

LRMR Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Net Income-$165.7M-105.5%-$80.6M-118.1%-$36.9M-4.5%-$35.4M+30.2%-$50.6M-19.2%-$42.5M-83.7%-$23.1M+62.3%-$61.4M-18.0%-$52.0M+10.1%-$57.9M+22.1%-$74.3M-103.6%-$36.5M-160.1%-$14.0M-1.1%-$13.9M

LRMR Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$32.8M-25.2%-$29.6M-1.1%N/A-$47.7M-207.8%-$26.2M-21.1%-$29.3M-99.8%N/A-$15.5M-71.0%-$21.6M-158.5%-$14.7M-124.5%N/A-$9.1M-8.9%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Larimar Therapeutics, Inc. financials

Frequently Asked Questions

What was Larimar Therapeutics, Inc.'s net income in fiscal year 2025?

Larimar Therapeutics, Inc. reported a net loss of $165.7M in fiscal year 2025.

How fast is Larimar Therapeutics, Inc.'s net income growing?

Larimar Therapeutics, Inc. (LRMR) net income fell by 105.5% year over year, from -$80.6M to -$165.7M in fiscal year 2025.

How has Larimar Therapeutics, Inc.'s net income changed over the years?

Across the 14 fiscal years this page covers, Larimar Therapeutics, Inc. (LRMR) net income went from -$13.9M in fiscal year 2012 to -$165.7M in fiscal year 2025.

Larimar Therapeutics, Inc. (LRMR) reported -$32.8M in net income in Q2 2026. This represents a decrease of 25.2% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Larimar Therapeutics, Inc. (LRMR) reported on that line in every period on record.